Clinical Trials Search at Vanderbilt-Ingram Cancer Center

CY 6031 A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CK3773274 IN ADULTS WITH SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY AND LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION

Disease Sites:

Not Available

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Brinkley, Douglas

Participating Institutions:

Vanderbilt University

Open Date:

03-23-2022

Trial Type:

Other

Protocol ID:

CRE-CHF0007

National Clinical Trial ID:

NCT05186818

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available